Evidence map›Paper›PMID 33986623›Full record

ArticleDegenerative neurological and neuromuscular disease2021

Melatonin Improves Short-Term Spatial Memory in a Mouse Model of Alzheimer's Disease.

Samah Labban, Fahad S Alshehri, Maher Kurdi, Yasser Alatawi, Badrah S Alghamdi

Open access · diamondAbstract read
In one paragraph

Article in Degenerative neurological and neuromuscular disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Cognitive and anti-inflammatory effects ofFrontiers in neuroscience · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. [Study on effects of 40 Hz light flicker stimulation on spatial working memory in rats and its neural mechanism].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Article
  12. Article
  13. Article
  14. Melatonin: A Neurotrophic Factor?Molecules (Basel, Switzerland) · 2022
    Review
  15. Article
  16. Deciphering the Link Between ERFrontiers in aging neuroscience · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Samah LabbanDepartment of Physiology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0001-8714-0062
Fahad S AlshehriDepartment of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.ORCID 0000-0001-6966-0128
Maher KurdiDepartment of Pathology, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia.
Yasser AlatawiDepartment of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Badrah S AlghamdiDepartment of Physiology, Neuroscience Unit, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0002-9411-3609
King Abdulaziz University · SAUmm al-Qura University · SAUniversity of Tabuk · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAlzheimer's disease (AD) is a neurodegenerative disease that has become a leading cause of death in recent years. Impairments in spatial learning and memory are an important clinical feature of AD. Melatonin (MLT), the main product secreted by the pineal gland, showed multiple antioxidant, anti-inflammatory, and neuroprotective properties. PURPOSE: The present study aimed to explore the possible prophylactic effects of MLT against spatial memory deficits in a sporadic mouse model of AD induced by D-galactose and aluminium chloride (AlCl

methodsFour groups of mice (

resultsWe found that MLT improved spatial memory in the sporadic AD mice. MLT ameliorated

conclusionMLT could have a substantial potential to alleviate memory impairment in sporadic AD if introduced at early stages.

Indexed as

Alzheimer’s diseaseBDNFCREBmelatoninspatial memory

Identifiers

PMID33986623
PMCPMC8110255
OpenAlexW3159263185

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.